This Article Full Text Full Text (PDF) All Versions of this Article: 35/5/1090    most recent 01.STR.0000124123.76658.6cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jannes, J. Articles by Koblar, S. A. Search for Related Content PubMed PubMed Citation Articles by Jannes, J. Articles by Koblar, S. A. Related Collections Genetics of Stroke

(Stroke. 2004;35:1090.)
© 2004 American Heart Association, Inc.

Original Contributions

Tissue Plasminogen Activator –7351C/T Enhancer Polymorphism Is a Risk Factor for Lacunar Stroke

Jim Jannes, BM, BS; Monica A. Hamilton-Bruce, PhD; Louis Pilotto, PhD; Brian J. Smith, PhD; Charles G. Mullighan, MD; Peter G. Bardy, MBBS Simon A. Koblar, PhD

From Departments of Medicine (J.J., S.K.), Neurology (M.H.-B.), and Respiratory Medicine (B.J.S.), University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia; Department of General Practice (L.P.), Flinders Medical Centre, Bedford Park, South Australia; Department of Haematology (C.G.M.), The Royal Adelaide Hospital, Adelaide, South Australia; Research and Development/Transplant Services (P.G.B.), Australian Red Cross–South Australian Branch, Adelaide, South Australia.

Correspondence to Dr Simon Koblar, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville, South Adelaide, South Australia 5011. E-mail simon.koblar{at}adelaide.edu.au

Background and Purpose— Occlusive thrombosis is an important component of small- and large-vessel ischemic stroke. Endogenous tissue plasminogen activator (TPA) is the primary mediator of intravascular fibrinolysis and is predominantly expressed by the endothelium of small vessels. The acute release of TPA is influenced by the TPA –7351C/T polymorphism and therefore may play an important role in the pathogenesis of lacunar stroke. In this study, we investigated the risk of lacunar and nonlacunar ischemic stroke associated with the TPA –7351C/T polymorphism.

Methods— We conducted a case-control study of 182 cases of ischemic stroke and 301 community controls. Participants were evaluated for known cerebrovascular risk factors, and the TPA –7351C/T genotype was established by a polymerase chain reaction (PCR) method. Logistic regression was used to determine the risk of lacunar and nonlacunar ischemic stroke associated with the TPA –7351C/T polymorphism.

Results— The prevalence of the TPA –7351 CC, CT, and TT genotypes were 46%, 45%, and 9% for controls and 41%, 46%, and 13% for stroke patients, respectively. After adjustment for known cerebrovascular risk factors, the TT genotype was significantly associated with ischemic stroke (OR: 1.9; 95% CI: 1.01 to 3.6). Stratification for stroke subtype showed a significant association between the TT genotype and lacunar stroke but not nonlacunar stroke (OR: 2.7; 95% CI: 1.1 to 6.7).

Conclusions— The TPA –7351C/T polymorphism is an independent risk factor for lacunar stroke. The findings suggest that impaired fibrinolysis may play a role in the pathogenesis of lacunar stroke.

Key Words: genetics • polymorphism • lacunar infarction • tissue plasminogen activator

This article has been cited by other articles:

				S. Kathiresan, Q. Yang, M. G. Larson, A. L. Camargo, G. H. Tofler, J. N. Hirschhorn, S. B. Gabriel, and C. J. O'Donnell Common Genetic Variation in Five Thrombosis Genes and Relations to Plasma Hemostatic Protein Level and Cardiovascular Disease Risk Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1405 - 1412. [Abstract] [Full Text] [PDF]

				W. Ridderstrale, E. Ulfhammer, S. Jern, and T. Hrafnkelsdottir Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy Hypertension, April 1, 2006; 47(4): 686 - 691. [Abstract] [Full Text] [PDF]

				A. G. Milton, J. Jannes, M. A. Hamilton-Bruce, S. A. Koblar, N. Jeck, S. Waldegger, B. Wissinger, M. Schwab, and F. Lang Activating Mutation of the Renal Epithelial Chloride Channel ClC-Kb Predisposing to Hypertension * Response: ClC-Kb Mutation Revisited Hypertension, March 1, 2006; 47(3): e12 - e13. [Full Text] [PDF]

				C. A. Armstrong, S. N. Bevan, K. T. Gormley, H. S. Markus, S. A. Koblar, J. Jannes, A. M. Hamilton-Bruce, and S. A. Koblar Tissue Plasminogen Activator -7351C/T Polymorphism and Lacunar Stroke * Response: Stroke, February 1, 2006; 37(2): 329 - 330. [Full Text] [PDF]

				J. E. Freedman Molecular Regulation of Platelet-Dependent Thrombosis Circulation, October 25, 2005; 112(17): 2725 - 2734. [Abstract] [Full Text] [PDF]

				K. Jood, P. Ladenvall, A. Tjarnlund-Wolf, C. Ladenvall, M. Andersson, S. Nilsson, C. Blomstrand, and C. Jern Fibrinolytic Gene Polymorphism and Ischemic Stroke Stroke, October 1, 2005; 36(10): 2077 - 2081. [Abstract] [Full Text] [PDF]

				A. T. Wolf, R. L. Medcalf, and C. Jern The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid Blood, February 1, 2005; 105(3): 1060 - 1067. [Abstract] [Full Text] [PDF]

				M. Saeed, A. Slowik, A. Borratynska, T. Dziedzic, A. Szczudlik, A. Kieltyka, and D. A. Figlewicz ACE and Subarachnoid Hemorrhage: Strategies for Genetics of Stroke * Response: Stroke, December 1, 2004; 35(12): 2752 - 2753. [Full Text] [PDF]